Early research (Phase 1)Study completedNCT00002373
What this trial is testing
The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients
Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56